AUGMENT: A Phase Iii Randomized Study of Lenalidomide Plus Rituximab (R-2) Vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

AuthID
 P-00Q-938
21
Author(s)
Leonard, JP
·
Fowler, NH
·
Hong, XN
·
Zhu, J
·
Zhang, HL
·
Offner, F
·
Scheliga, A
·
Nowakowski, GS
·
[+1]·
Re, F
·
Fogliatto, LM
·
Scheinberg, P
·
Flinn, IW
·
Moreira, C
·
Liu, D
·
Kalambakas, S
·
Fustier, P
·
Wu, CQ
·
Gribben, JG
View all authors
Document Type
Abstract
Year published
2018
Published
in BLOOD, ISSN: 0006-4971
Volume: 132
Conference
60Th Annual Meeting of the American-Society-Of-Hematology (Ash), Date: DEC 01-04, 2018, Location: San Diego, CA, Sponsors: Amer Soc Hematol
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000454837601154
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Name   Name Order Name   Name Order Name
1 Leonard, JP;   2 Trneny, M;   3 Izutsu, K;
4 Fowler, NH;   5 Hong, XN;   6 Zhu, J;
7 Zhang, HL;   8 Offner, F;   9 Scheliga, A;
10 Nowakowski, GS;   11 Pinto, A;   12 Re, F;
13 Fogliatto, LM;   14 Scheinberg, P;   15 Flinn, IW;
16 Moreira, C;   17 Liu, D;   18 Kalambakas, S;
19 Fustier, P;   20 Wu, CQ;   21 Gribben, JG;

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service